Benzinga's Top Pre-Market Losers

Loading...
Loading...
Nektar Therapeutics
NKTR
dipped 24.19% to $10.50 in the pre-market session after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint. Zoltek Companies
ZOLT
shares dropped 10.05% to $16.65 in pre-market trading after Toray Industries agreed to buy Zoltek Companies for $16.75 per share. J. C. Penney Company
JCP
shares fell 8.54% to $9.53 in the pre-market trading after the company priced its underwritten public offering of 84.0 million shares of its common stock at $9.65 per share. Accenture
ACN
dipped 4.18% to $72.70 in the pre-market session after the company reported a rise in its fiscal fourth-quarter net income. For the current fiscal year, the company projected net income of $4.42 to $4.54 per share, versus analysts' expectations of $4.50 per share.
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Pre-Market Losers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...